iSERA Lifesciences Ltd (534920) — FY26 Annual Report | 5 September 2026

5 September 2026 · BSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

34th AGM scheduled for September 29, 2026 via video conference

🔄 What Changed

Net profit increased to ₹25.94 lakhs from ₹11.81 lakhs; revenue rose to ₹135.50 lakhs; no dividend recommended

🔮 What's Next

Board emphasized sustainable growth, digital transformation, and cautious expansion in IT services; no specific financial targets provided

💡 Investor Takeaway

The company is focusing on digital growth opportunities while maintaining financial discipline, but no dividend is planned for shareholders this year.

The 34th Annual General Meeting of iSERA Lifesciences Limited (formerly Covidh Technologies Limited) is scheduled for September 29, 2026 via video conference. The Notice and Annual Report for FY2025-26 were sent electronically to eligible members as of August 28, 2026. Shareholders can vote remotely from September 26 to 28, 2026 using MUFG Intime India's e-voting platform. The Board highlighted financial performance, including revenue growth to [amount context mismatch] lakhs and net profit of ₹25.94 lakhs for FY2025-26. No dividend was recommended. Key governance updates include new director appointments, board committee compositions, and compliance with SEBI and MCA regulations for virtual meetings.

📄 View Original Announcement (PDF)

📊 Stock Analysis — 534920 ✨ Ask AI About This

About iSERA Lifesciences Ltd (534920)

Information Technology · IT - Software · Listed on BSE

Market Cap: ₹121.01 CrROE: -6.2%ROCE: 2.5%

View full 534920 stock details →

📡 Get AI alerts when 534920 files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track 534920 — Free

💡 Ask AI about this filing

"What is the expected revenue growth rate for FY2027?""How will the rights issue affect share dilution?""What are the key risks in the company's digital transformation strategy?"

Ask AI Free →

📊 More 534920 filings

🔴 Corporate Action — 1 October 2026iSERA Lifesciences announced the allotment of 1,61,82,800 equity shares at Rs 48.20 per share via sh...
🟡 Board Meeting — 1 October 2026The board approved the allotment of 1,61,82,800 equity shares at Rs 48.20 per share via share swap t...
🟡 Board Meeting — 29 September 2026iSERA Lifesciences held its 34th Annual General Meeting on 29 September 2026 via video conference, w...
Announcement — 28 September 2026iSERA Lifesciences announced that its trading window will close on October 1, 2026, and remain close...
🟡 Board Meeting — 1 September 2026The board fixed September 29, 2026 as the date for the 34th Annual General Meeting to approve the au...

See all 534920 filings →

🔥 Also filed on 5 September 2026

MTARTECHMTAR Technologies LtdAnnual Report 544877Technocrats Plasma Systems LtdFinancial Results 519285Tarai Foods LtdFinancial Results 526827Spice Islands Industries LtdFinancial Results 539189Adhbhut Infrastructure LtdAnnual Report PARAGMILKParag Milk Foods LtdAnnual Report

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts for your stocks — summarized by AI daily

Set up your AI Radar — pick stocks, get daily email summaries of new filings.

Set up AI Radar — Free

Free account · 2 AI queries/day

Tools